drugset / Trial / NCT07110883
A Clinical Study of SYS6023 in Patients With Advanced Solid Tumors
Non-randomizedSingle-groupOpen-labelTreatment
Summary
This is an open-label, dose-escalation and cohort-expansion, multicenter Phase I study involving participants with advanced solid tumors.
Timeline
- Start
- 2024-08-15
- Primary completion
- 2026-10-31
- Completion
- 2028-10-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | SYS6023 | Other / unclassified | 0.5 mg/kg | Intravenous |
| Subject | SYS6023 | Other / unclassified | 6.5 mg/kg | Intravenous |